From: FDG-PET/CT in intensive care patients with bloodstream infection
 | Example |
---|---|
1 | Patients continue to receive (medication dissolved in) intravenous glucose shortly before FDG-PET/CT. This can occur especially in ICU patients receiving multiple intravenous solutions |
2 | All intravenous glucose infusions are stopped appropriately, but enteral nutrition (through a nasogastric tube) is not |
3 | Patients receive intermediate or long-acting insulin on the day FDG-PET/CT is performed or rapid-acting insulin hours before FDG-PET/CT, either through continuous intravenous infusion or bolus injection |
4 | All sources of carbohydrates are stopped 4–6 h before FDG-PET/CT, but the treating physicians are specifically interested in the evaluation of endocarditis, and therefore a timeframe of 24 h would have been appropriate |
5 | Patients are kept in a cold environment shortly before FDG-PET/CT resulting in brown fat activation, especially in children |
6 | FDG-PET/CT is performed in patients with kidney and/or liver failure, potentially resulting in reduced background clearance, reduced metabolism of FDG, and poor image quality |